Sodium glucose co transporter 2 inhibitors and Ramadan: Another string to the bow
- PMID: 25364690
- PMCID: PMC4193001
- DOI: 10.4103/2230-8210.141397
Sodium glucose co transporter 2 inhibitors and Ramadan: Another string to the bow
References
-
- Salti I, Bénard E, Detournay B, Bianchi-Biscay M, Le Brigand C, Voinet C, et al. A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: Results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study. Diabetes Care. 2004;27:2306–11. - PubMed
-
- Casablanca, Morocco: FRSMR; 1995. International Meeting on Diabetes and Ramadan Recommendations.Edition of the Hassan II Foundation for Scientific and Medical Research on Ramadan.
-
- Pan C, Yang W, Barona JP, Wang Y, Niggli M, Mohideen P, et al. Comparison of vildagliptin and acarbose monotherapy in patients with type 2 diabetes: A 24-week, double-blind, randomized trial. Diabet Med. 2008;25:435–41. - PubMed
-
- Devendra D, Gohel B, Bravis V, Hui E, Salih S, Mehar S, et al. Vildagliptin therapy and hypoglycaemia in Muslim type 2 diabetes patients during Ramadan. Int J Clin Pract. 2009;63:1446–50. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources